NOELLE DECELL: Open Payments
NPI 1609572791 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 49 payments from 21 companies in 2025. Trend: 2023 $455 · 2024 $905 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Amgen Inc. | 4 | $59 |
| Astellas Pharma US Inc | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $40 |
| DePuy Synthes Sales Inc. | 1 | $38 |
| Novo Nordisk Inc | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
Products named: VRAYLAR, Veozah, OTEZLA, UBRELVY, Auvelity, Dexcom G6 Transmitter, MOTOBAND, JARDIANCE.
Industry payments across TX — which companies pay providers there.
